Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection

Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial

(2016) Diane M. Citron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection

(2016) M.J.T. Crobach et al.   CLINICAL MICROBIOLOGY AND INFECTION

Surotomycin versus vancomycin forClostridium difficileinfection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial

(2016) Christine H. Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Burden of Clostridium difficile Infection in the United States

(2015) Fernanda C. Lessa et al.   NEW ENGLAND JOURNAL OF MEDICINE

The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010

(2014) Kelly R. Reveles et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Clostridium difficile and the microbiota

(2014) Anna M. Seekatz et al.   JOURNAL OF CLINICAL INVESTIGATION

Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

(2012) D. R. Snydman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current Status of Clostridium difficile Infection Epidemiology

(2012) F. C. Lessa et al.   CLINICAL INFECTIOUS DISEASES

High Horn’s index score predicts poor outcomes in patients with Clostridium difficile infection

(2011) V. Arora et al.   JOURNAL OF HOSPITAL INFECTION

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain

(2009) Jennifer R. O'Connor et al.   GASTROENTEROLOGY

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE